16th May, 2025

Launch of Paracetamol 1000mg/100ml Solution for Infusion

Bowmed Ibisqus is pleased to announce the launch of Paracetamol vials.  The product is a standard 1000mg/100ml (10mg/ml) dose presented in a 10 pack and adds to our Analgesics range.

The glass vial combines a high-quality label with a built-in hanging mechanism designed explicitly for ready to administer intravenous bottles. The outer carton has clear labelling identifying the product on all prime faces and there is a perforated panel on the top of the carton for ease of access. A hard copy of our dosing poster is available on request or via emc

This new product line has been listed with AAH under code PAR1317A and stock is available for customers effective immediately.

If you would like to discuss a pricing arrangement or stock availability for Paracetamol or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us

 
 
5th May, 2025

Launch of Dopamine Hydrochloride 200mg/5ml Concentrate for Solution for Infusion

Bowmed Ibisqus is pleased to announce the launch of Dopamine ampoules. The product is a 200mg/5ml dose presented in a 5 pack of ampoules and adds to our Cardiovascular range.

Dopamine concentrate for solution for infusion is a medication used to correct hemodynamic imbalances in various conditions. Dopamine should be administered by intravenous infusion only after dilution with the appropriate diluents. The high-quality, coated cardboard insert is designed to securely house the ampoule and is made from environmentally friendly recyclable materials.

This new product line has been listed with AAH under code DOP0066P and stock is available for customers effective immediately.

If you would like to discuss a pricing arrangement or stock availability for Dopamine or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us

 
 
1st May, 2025

Launch of Sugammadex 200 mg/2 ml Solution for injection

Bowmed Ibisqus is pleased to announce the launch of Sugammadex vials. The product is a 200mg/2ml dose presented in a 10-pack vial for intravenous administration as a single bolus injection. Sugammadex is a medication for the reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults and rocuronium in paediatric patients.

This new product line has been listed with AAH under code SUG0045C and stock is available for customers effective immediately.

The 500mg/5ml dose of this product will also follow later in 2025 and we will announce the launch in due course.

If you would like to discuss a pricing arrangement or stock availability for Sugammadex or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us

 
 
24th May, 2024

Launch of Ready to Use IV Ropivacaine 400mg/200ml (2mg/ml) Bag

Bowmed Ibisqus is pleased to announce the launch of a Ready to Use Ropivacaine Bag.  The product is a standard 400mg/200ml (2mg/ml) dose presented in a 5 pack and adds to our anaesthesia range. The bag is packaged with a foil overwrap to protect the product from light and the overwrap clearly displays the essential product information.

This new product line has been listed with AAH under code ROP0089C and stock is available for customers effective immediately.

If you would like to discuss a pricing arrangement or stock availability for Ropivacaine Bags or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us

 
 
2nd February, 2024

Launch of Ertapenem 1g Vial x 10pk

Bowmed Ibisqus is pleased to announce the launch of Ertapenem 1g Vial in a 10 pack presentation.

Ertapenem is an addition to our range of carbapenem antibiotics and is licensed for the treatment of abdominal infections, acute gynaecological infections, community-acquired pneumonia, surgical prophylaxis, and colorectal surgery.

The new product has been listed with AAH under code ERT0005B.

If you would like to discuss a pricing arrangement or stock availability for Ertapenem or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us

 
 
14th March, 2023

Launch of Teicoplanin 200mg & 400mg IV Vials

Bowmed Ibisqus is pleased to announce the launch of our Teicoplanin IV Vials distributed in strengths of 200mg and 400mg.

Teicoplanin is a glycopeptide antibiotic with bactericidal activity against aerobic and anaerobic Gram-positive bacteria including multi-resistant staphylococci. Around 2 million doses of this product are administered in the UK each year and our launch will further reinforce the UK supply chain for this essential medicine.

The new products have been listed with AAH under codes TEI0008S (200mg) & TEI0007W (400mg). Stock is available for customers effective immediately.

If you would like to discuss a pricing arrangement or stock availability for Teicoplanin or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us